Varicose Veins Treatment Devices Market
Varicose Veins Treatment Devices Market Growth 2025 to 2035
Market Overview
The global varicose veins treatment devices market is set for significant expansion, projected to grow from USD 866.2 million in 2025 to USD 1,977.3 million by 2035, registering a 7.8% CAGR over the forecast period. The increasing prevalence of varicose veins, rising patient awareness, and advancements in minimally invasive treatments are driving the market.
Key Market Trends & Growth Drivers
1. Advancements in Minimally Invasive Procedures
- Endovenous laser ablation (EVLA) has emerged as a highly effective, non-invasive procedure for varicose vein treatment.
- Growing demand for radiofrequency ablation and sclerotherapy is boosting market expansion.
2. Rising Prevalence of Varicose Veins
- Over 40 million people in the U.S. suffer from varicose veins, according to the Chicago Vein Institute.
- The condition is more common among women, the elderly, and obese individuals, increasing demand for treatment devices.
3. Increasing Healthcare Expenditure & Government Support
- Governments in North America and Europe are investing in vascular health programs.
- Reimbursement policies for minimally invasive treatments are supporting market growth.
Market Segmentation
| Segment |
Category |
Market Share (2025) |
|---|---|---|
|
Product Type |
Endovenous Laser Systems |
55% |
|
Radiofrequency Ablation Devices |
25% | |
|
Sclerotherapy Products |
20% | |
|
Treatment Type |
Non-Thermal Ablation |
45% |
|
Thermal Ablation |
35% | |
|
Sclerotherapy |
20% | |
|
End User |
Hospitals |
50% |
|
Ambulatory Surgical Centers |
30% | |
|
Specialty Clinics |
20% |
Regional Insights
North America
- Expected to dominate with 45% of market share in 2025.
- High healthcare spending and advanced medical infrastructure drive growth.
Europe
- Forecasted to hold 28% of the market by 2025.
- Countries like Germany, the UK, and France have strong reimbursement policies and cutting-edge vascular treatments.
Asia-Pacific
- Fastest-growing region, with a 7.9% CAGR from 2025 to 2035.
- China and India are major markets, driven by rising awareness and increasing disposable income.
Challenges & Market Restraints
- Post-Treatment Side Effects: Some patients experience skin discoloration, bruising, and inflammation post-treatment.
- Availability of Alternative Treatments: Traditional methods like high ligation, vein stripping, and herbal remedies limit device adoption.
- Lack of Awareness in Developing Regions: Limited access to advanced healthcare facilities in low-income regions may hinder market expansion.
Competitive Landscape
Key Players in the Market
- Medtronic
- AngioDynamics Inc.
- Syneron Medical Ltd.
- Alma Lasers Ltd.
- LSO Medical
- Energist Ltd.
Recent Industry Developments
- Venclose Inc. received FDA approval for Venclose Maven, a radiofrequency ablation catheter for minimally invasive treatment of varicose veins.
- THERACLION introduced SONOVEIN HD, the first extracorporeal ultrasound therapy device for varicose veins.
- I-VASC secured funding to develop VELEX, an innovative varicose vein treatment device.
Frequently Asked Questions (FAQs)
- What is the market size of the varicose veins treatment devices industry in 2025?
- The market is expected to reach USD 866.2 million in 2025.
- Which segment holds the largest market share?
- Endovenous laser systems lead with a 55% market share.
- What factors are driving market growth?
- Increased prevalence of varicose veins, advancements in minimally invasive treatments, and government healthcare initiatives.
- Which region is experiencing the fastest growth?
- Asia-Pacific, with a 7.9% CAGR from 2025 to 2035.
- What are the latest trends in the market?
- AI-powered diagnostics, robotic-assisted procedures, and advanced laser technologies.
Take Action Now!
Contact us today to access the full market report and gain valuable industry insights. Stay ahead of your competitors and make informed business decisions!